GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Curatis Holding AG (XSWX:CURN) » Definitions » Price-to-Owner-Earnings

Curatis Holding AG (XSWX:CURN) Price-to-Owner-Earnings : (As of May. 29, 2025)


View and export this data going back to 2022. Start your Free Trial

What is Curatis Holding AG Price-to-Owner-Earnings?

As of today (2025-05-29), Curatis Holding AG's share price is CHF10.85. Curatis Holding AG does not have enough data to calculate Owner Earnings per Share (TTM), so as pPrice-to-Owner-Earnings.


The historical rank and industry rank for Curatis Holding AG's Price-to-Owner-Earnings or its related term are showing as below:


XSWX:CURN's Price-to-Owner-Earnings is not ranked *
in the Drug Manufacturers industry.
Industry Median: 24.945
* Ranked among companies with meaningful Price-to-Owner-Earnings only.

As of today (2025-05-29), Curatis Holding AG's share price is CHF10.85. Curatis Holding AG's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2024 was CHF-163.76. Therefore, Curatis Holding AG's PE Ratio (TTM) for today is At Loss.

As of today (2025-05-29), Curatis Holding AG's share price is CHF10.85. Curatis Holding AG's EPS without NRI for the trailing twelve months (TTM) ended in was CHF-6.25. Therefore, Curatis Holding AG's PE Ratio without NRI for today is At Loss.


Curatis Holding AG Price-to-Owner-Earnings Historical Data

The historical data trend for Curatis Holding AG's Price-to-Owner-Earnings can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Curatis Holding AG Price-to-Owner-Earnings Chart

Curatis Holding AG Annual Data
Trend Dec21 Dec22 Dec23
Price-to-Owner-Earnings
- - -

Curatis Holding AG Semi-Annual Data
Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
Price-to-Owner-Earnings Get a 7-Day Free Trial - - - - -

Competitive Comparison of Curatis Holding AG's Price-to-Owner-Earnings

For the Drug Manufacturers - Specialty & Generic subindustry, Curatis Holding AG's Price-to-Owner-Earnings, along with its competitors' market caps and Price-to-Owner-Earnings data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Curatis Holding AG's Price-to-Owner-Earnings Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Curatis Holding AG's Price-to-Owner-Earnings distribution charts can be found below:

* The bar in red indicates where Curatis Holding AG's Price-to-Owner-Earnings falls into.


;
;

Curatis Holding AG Price-to-Owner-Earnings Calculation

In 1986 Berkshire Hathaway Shareholder Letter, Warren Buffett defined owner earnings as follows:

"These represent (a) reported earnings plus (b) depreciation, depletion, amortization, and certain other non-cash charges...less (c) the average annual amount of capitalized expenditures for plant and equipment, etc. that the business requires to fully maintain its long-term competitive position and its unit volume. (If the business requires additional working capital to maintain its competitive position and unit volume, the increment also should be included in (c))...Our owner-earnings equation does not yield the deceptively precise figures provided by GAAP, since (c) must be a guess - and one sometimes very difficult to make. Despite this problem, we consider the owner earnings figure, not the GAAP figure, to be the relevant item for valuation purposes - both for investors in buying stocks and for managers in buying entire businesses...All of this points up the absurdity of the 'cash flow' numbers that are often set forth in Wall Street reports. These numbers routinely include (a) plus (b) - but do not subtract (c)."

Curatis Holding AG's Price-to-Owner-Earnings for today is calculated as

Price-to-Owner-Earnings=Share Price/Owner Earnings per Share (TTM)
=10.85/0.00
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Curatis Holding AG  (XSWX:CURN) Price-to-Owner-Earnings Explanation

For how to get Owner Earnings per Share (TTM), please click.


Curatis Holding AG Price-to-Owner-Earnings Related Terms

Thank you for viewing the detailed overview of Curatis Holding AG's Price-to-Owner-Earnings provided by GuruFocus.com. Please click on the following links to see related term pages.


Curatis Holding AG Business Description

Traded in Other Exchanges
Address
Weierweg 7, Liestal, CHE, CH-4410
Curatis Holding AG is a specialty pharmaceutical company based in Switzerland. It focus on the acquisition, development and commercialisation of medicines for the prevention, diagnosis and treatment of rare and specialty care diseases. Curatis is engaged in two business areas: Distribution business for orphan disease and specialty care medicines and Development business for orphan and specialty care disease medicines. Its product include Aggrastat (Tirofiban), AmbiFul (Fulvestrant), Brinavess (Vernakalant), Coldistop, Cuprior (Trientin), Cyanokit (Hydroxocobalamin), etc.